Innoviva Inc (INVA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $23.54
• Market Cap: $1.66B
• P/E Ratio: 13.37
• EPS: $1.66
• 52-Week High: $24.25
• 52-Week Low: $16.52

Market Sentiment

Innoviva Inc currently has a Bullish sentiment score of 0.37.

About Innoviva Inc

Innoviva, Inc. is a biopharmaceutical company headquartered in Burlingame, California, specializing in the development and commercialization of innovative therapies targeting respiratory diseases. The company leverages proprietary technologies and strategic collaborations with leading healthcare partners to create advanced treatment solutions that significantly enhance patient outcomes. With a diverse and robust pipeline, Innoviva is dedicated to addressing pressing unmet medical needs and ad...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Innoviva Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does INVA pay dividends?

Innoviva Inc (INVA) does not currently pay a regular dividend.

What is INVA's P/E ratio?

Innoviva Inc has a price-to-earnings (P/E) ratio of 13.37.

What is INVA's market cap?

Innoviva Inc (INVA) has a market capitalization of $1.66B with a current stock price of $23.54.